Transplant outcomes after intensive chemotherapy or venetoclax plus azacitidine in acute myeloid leukemia: a multicenter retrospective study in Japan.

Muranushi H, Kanda J, Kondo T, Arai Y, Okamura-Shiki I, Ikeda T, Amagase H, Okuda T, Nakagawa D, Maeda T, Ueda Y, Imada K, Yago K, Takeoka T, Okada M, Miyahara Y, Watanabe M, Arima N, Kitano T, Hishizawa M, Io K, Oka S, Asagoe K, Akasaka T, Yamashita K, Takaori-Kondo A

Open source

DOI: 10.46989/001c.170281
Published: 2026
Container: Clinical hematology international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.46989/001c.170281,
  title = {Transplant outcomes after intensive chemotherapy or venetoclax plus azacitidine in acute myeloid leukemia: a multicenter retrospective study in Japan.},
  author = {Muranushi H and Kanda J and Kondo T and Arai Y and Okamura-Shiki I and Ikeda T and Amagase H and Okuda T and Nakagawa D and Maeda T and Ueda Y and Imada K and Yago K and Takeoka T and Okada M and Miyahara Y and Watanabe M and Arima N and Kitano T and Hishizawa M and Io K and Oka S and Asagoe K and Akasaka T and Yamashita K and Takaori-Kondo A},
  year = {2026},
  journal = {Clinical hematology international},
  doi = {10.46989/001c.170281},
  url = {https://doi.org/10.46989/001c.170281}
}

RIS

TY  - JOUR
TI  - Transplant outcomes after intensive chemotherapy or venetoclax plus azacitidine in acute myeloid leukemia: a multicenter retrospective study in Japan.
AU  - Muranushi H
AU  - Kanda J
AU  - Kondo T
AU  - Arai Y
AU  - Okamura-Shiki I
AU  - Ikeda T
AU  - Amagase H
AU  - Okuda T
AU  - Nakagawa D
AU  - Maeda T
AU  - Ueda Y
AU  - Imada K
AU  - Yago K
AU  - Takeoka T
AU  - Okada M
AU  - Miyahara Y
AU  - Watanabe M
AU  - Arima N
AU  - Kitano T
AU  - Hishizawa M
AU  - Io K
AU  - Oka S
AU  - Asagoe K
AU  - Akasaka T
AU  - Yamashita K
AU  - Takaori-Kondo A
PY  - 2026
JO  - Clinical hematology international
DO  - 10.46989/001c.170281
UR  - https://doi.org/10.46989/001c.170281
ER  -

APA

H, M., J, K., T, K., Y, A., I, O., T, I., H, A., T, O., D, N., T, M., Y, U., K, I., K, Y., T, T., M, O., Y, M., M, W., N, A., T, K., M, H., K, I., S, O., K, A., T, A., K, Y., & A, T. (2026). Transplant outcomes after intensive chemotherapy or venetoclax plus azacitidine in acute myeloid leukemia: a multicenter retrospective study in Japan.. Clinical hematology international. https://doi.org/10.46989/001c.170281

Source records

pubmed · retrieved 2026-09-26T05:37:34.581Z